New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease

Alberto J Lorenzatti1,2, Peter P Toth3,4

  • 1DAMIC Medical Institute, Rusculleda Foundation for Research, Cordoba, Argentina.

European Cardiology
|March 18, 2020
PubMed

Insights

Atherogenic dyslipidemia, marked by high triglycerides and low HDL cholesterol, significantly increases cardiovascular disease risk. Lifestyle changes and medications can manage these lipid abnormalities to reduce residual risk.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Lipidology

Background:

  • Atherogenic dyslipidemia is a prevalent lipid abnormality strongly linked to cardiovascular disease (CVD) risk.
  • Despite statin and non-statin therapies, residual CVD risk persists due to non-LDL cholesterol patterns.
  • These patterns include elevated triglycerides, low HDL cholesterol, small dense LDL particles, and postprandial hyperlipidaemia.

Purpose of the Study:

  • To review the pathophysiology of atherogenic dyslipidemia.
  • To explore its association with atherosclerotic cardiovascular disease development.
  • To outline therapeutic strategies for managing these lipid alterations and preventing CVD events.

Main Methods:

  • Literature review of pathophysiology.
  • Analysis of the relationship between lipid profiles and atherosclerosis.
  • Summary of current lifestyle and pharmacological interventions.

Main Results:

  • Atherogenic dyslipidemia is associated with insulin resistance, type 2 diabetes, and obesity.
  • These lipid modifications contribute to increased atherosclerotic cardiovascular disease risk.
  • Therapeutic approaches involve lifestyle modifications and pharmacological treatments.

Conclusions:

  • Atherogenic dyslipidemia represents a significant challenge in cardiovascular disease prevention.
  • Understanding its pathophysiology is crucial for effective management.
  • A combination of lifestyle changes and targeted therapies is necessary to mitigate residual cardiovascular risk.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
272
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
792
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
684
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
510